Table of Content



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Overview
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Companies Involved in Therapeutics Development
ALS Biopharma LLC
Bio-Pharm Solutions Co Ltd
Nobias Therapeutics Inc
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Drug Profiles
FC-3423 - Drug Profile
Product Description
Mechanism Of Action
History of Events
JBPOS-0101 - Drug Profile
Product Description
Mechanism Of Action
History of Events
NB-001 - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Agonize mGlu1 for Schizophrenia - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecules to Antagonize mGluR1 for Depression - Drug Profile
Product Description
Mechanism Of Action
VU-0467558 - Drug Profile
Product Description
Mechanism Of Action
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Dormant Products
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Discontinued Products
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Product Development Milestones
Featured News & Press Releases
Dec 08, 2021: A potential new approach for the treatment of schizophrenia
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


List of Figures
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Top 10 Indications, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables


List of Tables
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Indication, 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products under Investigation by Universities/Institutes, 2022
Products under Investigation by Universities/Institutes, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Pipeline by ALS Biopharma LLC, 2022
Pipeline by Bio-Pharm Solutions Co Ltd, 2022
Pipeline by Nobias Therapeutics Inc, 2022
Dormant Projects, 2022
Discontinued Products, 2022